China Money Network
Login
Join

EverSea Medicines Acquires Hasten Biopharmaceuticals (Asia) Limited Shares

  • April 8, 2026 — 13:35 CST

This Data Is Locked!

This area is available only to Subscribers.

EverSea Medicines, a subsidiary of Everest Medicines, has signed an agreement to acquire the equity interest in Hasten Biopharmaceuticals (Asia) Limited.

The acquisition positions Everest... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: